Long-term treatment with tocilizumab in giant cell arteritis: efficacy and safety in a monocentric cohort of patients.

Regola, Francesca; Cerudelli, Elisabetta; Bosio, Giovanni; Andreoli, Laura; Tincani, Angela; Franceschini, Franco; Toniati, Paola

Regola, Francesca; Cerudelli, Elisabetta; Bosio, Giovanni; Andreoli, Laura; Tincani, Angela; Franceschini, Franco; Toniati, Paola.

Afiliação

Regola F; Rheumatology and Clinical Immunology Unit, ASST Spedali Civili di Brescia.
Cerudelli E; Department of Clinical and Experimental Sciences, University of Brescia.
Bosio G; Nuclear Medicine Unit, ASST Spedali Civili di Brescia, Brescia, Italy.
Andreoli L; Nuclear Medicine Unit, ASST Spedali Civili di Brescia, Brescia, Italy.
Tincani A; Rheumatology and Clinical Immunology Unit, ASST Spedali Civili di Brescia.
Franceschini F; Department of Clinical and Experimental Sciences, University of Brescia.
Toniati P; Rheumatology and Clinical Immunology Unit, ASST Spedali Civili di Brescia.

Rheumatol Adv Pract ; 4(2): rkaa017, 2020.

Article em En | MEDLINE | ID: mdl-32685912

Palavras-chave

fluorodeoxyglucose-PET/CT; giant cell arteritis; large vessel vasculitis; tocilizumab

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Risk_factors_studies Idioma: En Revista: Rheumatol Adv Pract Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google